According to the latest data from the Hong Kong Stock Exchange, on May 20, LAV Asset Management (Hong Kong) Limited increased its holding in DUALITYBIO-B (09606) by 105,000 shares. The transaction was executed at a price of HK$226.0879 per share, amounting to a total consideration of approximately HK$23.74 million. Following this purchase, the firm's latest shareholding stands at approximately 11.7579 million shares, representing a 13.00% stake in the company. The transaction involved other related parties, including Shi Yi. Supplementary information indicates that LAV Star Limited and LAV Star Opportunities Limited purchased 52,500 and 52,500 shares of Duality Biotherapeutics, Inc.–B, respectively, with a trade date of May 20, 2026 and a settlement date of May 22, 2026.